In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...